Her2 gene expression and not Her2 amplification is predictive and prognostic in patients (pts) with metastatic colorectal cancer (mCRC) enrolled in CALGB/SWOG 80405 (Alliance)
- Citation:
- J Clin Oncol vol 38 (15 suppl) abstr 4086
- Meeting Instance:
- ASCO 2020
- Year:
- 2020
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 3996
- Program:
- TRP
- Primary Committee:
- Correl Sci NOS
- Sec. Committees:
- Pharmas:
- BMS. Genentech, Pfizer, Sanofi
- Grants:
- U10CA180821, U10CA180882; U10CA180888, UG1CA180830 (SWOG)
- Corr. Author:
- Authors:
- Francesca Battaglin Fang-Shu Ou Xueping Qu Monica M. Bertagnolli Howard S. Hochster Donna Niedzwiecki Richard M. Goldberg Robert J. Mayer Tyler Zemla Charles D. Blanke Alan P. Venook Carlos Bias Heinz Josef Lenz Federico Innocenti
- Networks:
- CA011, CA136, LAPS-MA036, LAPS-MN026, LAPS-NC007, LAPS-OH007, OR013
- Study
- CALGB-80405
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: